GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Elizabeth Arden Inc (FRA:FR2) » Definitions » Ending Cash Position

Elizabeth Arden (FRA:FR2) Ending Cash Position : €40.1 Mil (As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Elizabeth Arden Ending Cash Position?

Elizabeth Arden's Ending Cash Position for the quarter that ended in Jun. 2016 was €40.1 Mil.

Elizabeth Arden's quarterly Ending Cash Position declined from Dec. 2015 (€50.0 Mil) to Mar. 2016 (€36.9 Mil) but then increased from Mar. 2016 (€36.9 Mil) to Jun. 2016 (€40.1 Mil).

Elizabeth Arden's annual Ending Cash Position declined from Jun. 2014 (€41.4 Mil) to Jun. 2015 (€41.1 Mil) and declined from Jun. 2015 (€41.1 Mil) to Jun. 2016 (€40.1 Mil).


Elizabeth Arden Ending Cash Position Historical Data

The historical data trend for Elizabeth Arden's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elizabeth Arden Ending Cash Position Chart

Elizabeth Arden Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.09 46.75 41.44 41.06 40.09

Elizabeth Arden Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.06 33.19 50.02 36.94 40.09

Elizabeth Arden Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Elizabeth Arden's Ending Cash Position for the fiscal year that ended in Jun. 2016 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=39.842+0.252
=40.1

Elizabeth Arden's Ending Cash Position for the quarter that ended in Jun. 2016 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=36.345+3.749
=40.1


Elizabeth Arden Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Elizabeth Arden's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Elizabeth Arden (FRA:FR2) Business Description

Traded in Other Exchanges
N/A
Address
Elizabeth Arden Inc is incorporated on June 26, 1992 in the state of Florida. The Company is a beauty products company with a portfolio of prestige fragrance, skin care and cosmetics brands. The Company's portfolio includes Elizabeth Arden Brand, Celebrity Fragrances, Heritage Fragrances and Designer Fragrances. In addition to its owned or licensed fragrance brands, the Company distributes additional prestige fragrance brands, in the United States through distribution and other purchasing agreements. It sells its prestige beauty products to retailers in the United States and internationally, including; U.S. prestige retailers and specialty stores such as Macy's, Dillard's, Ulta, Belk, Sephora, Bloomingdales and Nordstrom; U.S. mass retailers, including mid-tier and chain drug retailers, such as Wal-Mart, Target, Kohl's, Walgreens, CVS, and TJ Maxx and Marshalls; and International retailers such as Boots, Debenhams, Superdrug Stores, The Perfume Shop, Hudson's Bay, Shoppers Drug Mart, Myer, Douglas and various travel retail outlets such as Nuance, Heinemann and World Duty Free. The Company and its products are subject to regulation by the Food and Drug Administration, the Federal Trade Commission and state regulatory authorities in the United States, as well as by various other federal, local and international regulatory authorities in the countries in which its products are produced or sold.

Elizabeth Arden (FRA:FR2) Headlines

No Headlines